Onyx’s Kyprolis to Compete With Velcade After Winning Accelerated Approval for Multiple Myeloma
Onyx Pharmaceuticals’ Kyprolis just bagged accelerated approval for multiple myeloma patients who have received at least two prior therapies.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.